Evidence map›Paper›PMID 35968292›Full record

ArticleFrontiers in neurology2022

Preoperative Brain Tumor Imaging: Models and Software for Segmentation and Standardized Reporting.

David Bouget, André Pedersen, Asgeir S Jakola, Vasileios Kavouridis, Kyrre E Emblem, Roelant S Eijgelaar, Ivar Kommers, Hilko Ardon, Frederik Barkhof, Lorenzo Bello and 20 more

Abstract read
In one paragraph

Article in Frontiers in neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Deep learning in MRI-guided radiation therapy: A systematic review.Journal of applied clinical medical physics · 2024
    Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Clinical evaluation of two glioblastoma delineation methods based on neural networks.Technical innovations & patient support in radiation oncology · 2025
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

David BougetDepartment of Health Research, SINTEF Digital, Trondheim, Norway.
André PedersenDepartment of Health Research, SINTEF Digital, Trondheim, Norway.
Asgeir S JakolaDepartment of Neurosurgery, Sahlgrenska University Hospital, Gothenburg, Sweden.
Vasileios KavouridisDepartment of Neurosurgery, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
Kyrre E EmblemDivision of Radiology and Nuclear Medicine, Department of Physics and Computational Radiology, Oslo University Hospital, Oslo, Norway.
Roelant S EijgelaarDepartment of Neurosurgery, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, Netherlands.
Ivar KommersDepartment of Neurosurgery, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, Netherlands.
Hilko ArdonDepartment of Neurosurgery, Twee Steden Hospital, Tilburg, Netherlands.
Frederik BarkhofDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, Netherlands.
Lorenzo BelloNeurosurgical Oncology Unit, Department of Oncology and Hemato-Oncology, Humanitas Research Hospital, Università degli Studi di Milano, Milan, Italy.
Mitchel S BergerDepartment of Neurological Surgery, University of California, San Francisco, San Francisco, CA, United States.
Marco Conti NibaliNeurosurgical Oncology Unit, Department of Oncology and Hemato-Oncology, Humanitas Research Hospital, Università degli Studi di Milano, Milan, Italy.
Julia FurtnerDepartment of Biomedical Imaging and Image-Guided Therapy, Medical University Vienna, Wien, Austria.
Shawn Hervey-JumperDepartment of Neurological Surgery, University of California, San Francisco, San Francisco, CA, United States.
Albert J S IdemaDepartment of Neurosurgery, Northwest Clinics, Alkmaar, Netherlands.
Barbara KieselDepartment of Neurosurgery, Medical University Vienna, Wien, Austria.
Alfred KloetDepartment of Neurosurgery, Haaglanden Medical Center, The Hague, Netherlands.
Emmanuel MandonnetDepartment of Neurological Surgery, Hôpital Lariboisière, Paris, France.
Domenique M J MüllerDepartment of Neurosurgery, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, Netherlands.
Pierre A RobeDepartment of Neurology and Neurosurgery, University Medical Center Utrecht, Utrecht, Netherlands.
Marco RossiNeurosurgical Oncology Unit, Department of Oncology and Hemato-Oncology, Humanitas Research Hospital, Università degli Studi di Milano, Milan, Italy.
Tommaso SciortinoNeurosurgical Oncology Unit, Department of Oncology and Hemato-Oncology, Humanitas Research Hospital, Università degli Studi di Milano, Milan, Italy.
Wimar A Van den BrinkDepartment of Neurosurgery, Isala, Zwolle, Netherlands.
Michiel WagemakersDepartment of Neurosurgery, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Georg WidhalmDepartment of Neurosurgery, Medical University Vienna, Wien, Austria.
Marnix G WitteDepartment of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.
Aeilko H ZwindermanDepartment of Clinical Epidemiology and Biostatistics, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands.
Philip C De Witt HamerDepartment of Neurosurgery, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, Netherlands.
Ole SolheimDepartment of Neurosurgery, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
Ingerid ReinertsenDepartment of Health Research, SINTEF Digital, Trondheim, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For patients suffering from brain tumor, prognosis estimation and treatment decisions are made by a multidisciplinary team based on a set of preoperative MR scans. Currently, the lack of standardized and automatic methods for tumor detection and generation of clinical reports, incorporating a wide range of tumor characteristics, represents a major hurdle. In this study, we investigate the most occurring brain tumor types: glioblastomas, lower grade gliomas, meningiomas, and metastases, through four cohorts of up to 4,000 patients. Tumor segmentation models were trained using the AGU-Net architecture with different preprocessing steps and protocols. Segmentation performances were assessed in-depth using a wide-range of voxel and patient-wise metrics covering volume, distance, and probabilistic aspects. Finally, two software solutions have been developed, enabling an easy use of the trained models and standardized generation of clinical reports: Raidionics and Raidionics-Slicer. Segmentation performances were quite homogeneous across the four different brain tumor types, with an average true positive Dice ranging between 80 and 90%, patient-wise recall between 88 and 98%, and patient-wise precision around 95%. In conjunction to Dice, the identified most relevant other metrics were the relative absolute volume difference, the variation of information, and the Hausdorff, Mahalanobis, and object average symmetric surface distances. With our Raidionics software, running on a desktop computer with CPU support, tumor segmentation can be performed in 16-54 s depending on the dimensions of the MRI volume. For the generation of a standardized clinical report, including the tumor segmentation and features computation, 5-15 min are necessary. All trained models have been made open-access together with the source code for both software solutions and validation metrics computation. In the future, a method to convert results from a set of metrics into a final single score would be highly desirable for easier ranking across trained models. In addition, an automatic classification of the brain tumor type would be necessary to replace manual user input. Finally, the inclusion of post-operative segmentation in both software solutions will be key for generating complete post-operative standardized clinical reports.

Indexed as

3D segmentationdeep learninggliomameningiomametastasisMRIopen-source softwareRADS

Identifiers

PMID35968292
PMCPMC9364874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.